India looks to produce additional LCA Mk1A fighters
The Indian Air Force (IAF) seems close to have given up hope for the release of an RfP for 114 Multi-Role Fighter Aircraft (MRFA). Facing a fast-depleting fighter inventory, it is now considering increasing its order of Light Combat Aircraft (LCA) Mk1As from the planned 50 to 100.
This is in addition to 83 aircraft ordered two years ago, where delivery of ten trainers is to start by March 2024 and with the total order filled by 2028.
HAL’s two production facilities in Bangalore are expected to manufacture 16 LCA Mk1As per annum. Since LCA Mk2 production is not expected
Already have an account? Log in
Want to keep reading this article?
Read this Article
Get access to this article with a Free Basic Account
- Original curated content, daily across air, land and naval domains
- 2 free stories per week
- Daily news round-up email service
- Access to all Decisive Edge email newsletters
Unlimited Access
Access to all our premium news as a Premium News 365 Member. Corporate subscriptions available.
- Original curated content, daily across air, land and naval domains
- 14-day free trial (cancel at any time)
- Unlimited access to all published premium news
More from Air Warfare
-
Second tranche of UAVs for Replicator programme announced
The capabilities of the selected systems add to those in the first tranche announced earlier this year by the US Department of Defense.
-
UAE receives first additional A330 MRTT
The arrival of this aircraft boosts the UAE’s fleet of tankers up to four, following its order for an additional two aircraft in 2021.
-
Gray Eagle UAS makes first ship-to-shore journey
The Gray Eagle short take-off and landing (STOL) UAS has a different engine, wings, control surfaces and landing gear to earlier Gray Eagles, and is a production variant of the demonstrator Mojave UAS.
-
Collins Aerospace wins $19 million contract to upgrade RAF CH-47 Chinooks
The Chinook cockpit upgrade will enhance the UK RAF’s Chinooks’ collaboration with the US and improve operational effectiveness and safety, Collins have claimed.